Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

283 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 283 results

Large-scale testing (Phase 3)Ended earlyNCT05328908
What this trial is testing

Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bristol-Myers Squibb 770
Testing effectiveness (Phase 2)Study completedNCT02195011
What this trial is testing

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Neoplasms
SCRI Development Innovations, LLC 26
Testing effectiveness (Phase 2)Study completedNCT04126733
What this trial is testing

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

Who this might be right for
Colorectal Cancer
Bayer 70
Testing effectiveness (Phase 2)UnknownNCT05753163
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Who this might be right for
Colorectal Liver Metastasis
Fudan University 44
Testing effectiveness (Phase 2)UnknownNCT04718909
What this trial is testing

Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 166
Testing effectiveness (Phase 2)Active Not RecruitingNCT04781192
What this trial is testing

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer
University of Kansas Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Not applicableUnknownNCT05811481
What this trial is testing

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib
WenBo Guo 192
Testing effectiveness (Phase 2)Study completedNCT03793361
What this trial is testing

Phase II Study of Regorafenib as Maintenance Therapy

Who this might be right for
Metastatic Soft Tissue Sarcoma
Centre Oscar Lambret 127
Testing effectiveness (Phase 2)Study completedNCT00664326
What this trial is testing

A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 49
Large-scale testing (Phase 3)Looking for participantsNCT05462613
What this trial is testing

Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon 446
Not applicableUnknownNCT04771715
What this trial is testing

Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Carcinoma
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05877001
What this trial is testing

The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Peking University Cancer Hospital & Institute 20
Early research (Phase 1)Not Yet RecruitingNCT06283303
What this trial is testing

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 8
Testing effectiveness (Phase 2)WithdrawnNCT05730673
What this trial is testing

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Who this might be right for
CCR5Microsatellite StableMetastatic+1 more
CytoDyn, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05395741
What this trial is testing

Regorafenib in Patients With Refractory Primary Bone Tumors

Who this might be right for
OsteosarcomaEwing Sarcoma of Bone
Institute of Mother and Child, Warsaw, Poland 30
Testing effectiveness (Phase 2)Looking for participantsNCT07040228
What this trial is testing

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07392866
What this trial is testing

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Nanjing Sanhome Pharmaceutical, Co., Ltd. 120
Testing effectiveness (Phase 2)Temporarily pausedNCT07071961
What this trial is testing

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Who this might be right for
Colorectal CancerRegorafenibHigh Risk Patients
M.D. Anderson Cancer Center 16
Load More Results